Zoetis Inc. (NYSE:ZTS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, BofA downgraded ...

Zoetis Inc. (NYSE:ZTS) is included among the 15 Dividend Stocks with Low Payout Ratios and Strong Upside. On December 18, ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...

Zoetis (ZTS) has been beaten down lately with too much selling pressure. While the stock has lost 8.8% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...

Zoetis (ZTS) ended the recent trading session at $123.78, demonstrating a +1.26% change from the preceding day's closing price. This change outpaced the S&P 500's 0.64% gain on the day. Meanwhile, the ...

Zoetis Q2 EPS rose to $1.76 vs. $1.61 estimate; revenue hit $2.50 billion, beating $2.41 billion forecast. Full-year EPS guidance raised to $6.30–$6.40 from $6.20–$6.30. Want to trade this news? Get ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly valued at recent levels. Zoetis has a lot of growth potential. You would have done pretty well: ...

Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their ...

Zoetis Inc. Annual cash flow by MarketWatch. View ZTS net cash flow, operating cash flow, operating expenses and cash dividends.